Mechanisms of Protein Misfolding in Conformational Lung Diseases

被引:0
|
作者
McElvaney, N. G. [1 ]
Greene, C. M. [1 ]
机构
[1] Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Resp Res Div,Dept Med, Dublin 9, Ireland
基金
爱尔兰科学基金会;
关键词
Alpha-1; antitrypsin; cigarette smoke; cystic fibrosis transmembrane conductance regulator; endoplasmic reticulum stress; TRANSMEMBRANE CONDUCTANCE REGULATOR; MUTANT ALPHA-1-ANTITRYPSIN Z; MEDIATE INCREASED SECRETION; NUCLEOTIDE-BINDING DOMAIN; CYSTIC-FIBROSIS LUNG; Z ALPHA(1)-ANTITRYPSIN; ENDOPLASMIC-RETICULUM; NEUTROPHIL ELASTASE; CIGARETTE-SMOKE; SERPIN POLYMERIZATION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Genetic or environmentally-induced alterations in protein structure interfere with the correct folding, assembly and trafficking of proteins. In the lung the expression of misfolded proteins can induce a variety of pathogenetic effects. Cystic fibrosis (CF) and alpha-1 antitrypsin (AAT) deficiency are two major clinically relevant pulmonary disorders associated with protein misfolding. Both are genetic diseases the primary causes of which are expression of mutant alleles of the cystic fibrosis transmembrane conductance regulator (CFTR) and SERPINA1, respectively. The most common and best studied mutant forms of CFTR and AAT are Delta F508 CFTR and the Glu342Lys mutant of AAT called ZAAT, respectively. Non-genetic mechanisms can also damage protein structure and induce protein misfolding in the lung. Cigarette-smoke contains oxidants and other factors that can modify a protein's structure, and is one of the most significant environmental causes of protein damage within the lung. Herein we describe the mechanisms controlling the folding of wild type and mutant versions of CFTR and AAT proteins, and explore the consequences of cigarette-smoke-induced effects on the protein folding machinery in the lung.
引用
收藏
页码:850 / 859
页数:10
相关论文
共 50 条
  • [21] Nanomedicine and protein misfolding diseases
    Kransnoslobodtsev, Alexey V.
    Shlyakhtenko, Luda S.
    Ukraintsev, Egor
    Zaikova, Tatiana O.
    Keana, John F. W.
    Lyubchenko, Yuri L.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2005, 1 (04) : 300 - 305
  • [22] Protein dynamics, folding and misfolding: from basic physical chemistry to human conformational diseases
    Ferreira, ST
    De Felice, FG
    FEBS LETTERS, 2001, 498 (2-3) : 129 - 134
  • [23] Molecular mechanisms of nitrosative stress-mediated protein misfolding in neurodegenerative diseases
    T. Nakamura
    S. A. Lipton
    Cellular and Molecular Life Sciences, 2007, 64 : 1609 - 1620
  • [24] Molecular mechanisms of nitrosative stress-mediated protein misfolding in neurodegenerative diseases
    Nakamura, T.
    Lipton, S. A.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (13) : 1609 - 1620
  • [25] Protein Misfolding Diseases and Therapeutic Approaches
    Yadav, Kusum
    Yadav, Anurag
    Vashistha, Priyanka
    Pandey, Veda P.
    Dwivedi, Upendra N.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2019, 20 (12) : 1226 - 1245
  • [26] Nanoimaging for protein misfolding and related diseases
    Lyubchenko, Yuri L.
    Sherman, Simon
    Shlyakhtenko, Luda S.
    Uversky, Vladimir N.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (01) : 53 - 70
  • [27] Protein misfolding and degradation in genetic diseases
    Bross, P
    Corydon, TJ
    Andresen, BS
    Jorgensen, MM
    Bolund, L
    Gregersen, N
    HUMAN MUTATION, 1999, 14 (03) : 186 - 198
  • [28] Developing therapeutics for the diseases of protein misfolding
    May, BCH
    Govaerts, C
    Cohen, FE
    NEUROLOGY, 2006, 66 : S118 - S122
  • [29] Protein Misfolding and Neurodegenerative Diseases Introduction
    Diamond, Marc I.
    NEUROTHERAPEUTICS, 2013, 10 (03) : 369 - 370
  • [30] Chaperones and Cardiac Misfolding Protein Diseases
    Christians, Elisabeth S.
    Mustafi, Soumyajit B.
    Benjamin, Ivor J.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2014, 15 (03) : 189 - 204